Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 49,275 $ 58,910
Prepaid expenses 1,477 1,485
Accounts receivable from related party 4,000 0
Other current assets 144 19
Total current assets 54,896 60,414
Property and equipment, net 4,294 1,952
In-process research and development 26,623 26,623
Other assets 1,402 1,402
Total assets 87,215 90,391
Current liabilities:    
Accounts payable 2,859 2,517
Accrued liabilities 2,800 2,690
Current portion of long-term debt 0 2,400
Deferred revenue 6,350 2,765
Other current liabilities 98 70
Total current liabilities 12,107 10,442
Warrant liabilities 340 954
Long-term debt, net 2,999 1,078
Other liabilities 828 628
Total liabilities 16,274 13,102
Commitments and contingencies (Note 9)
Stockholders’ equity    
Common stock, $0.001 par value, shares authorized: 150,000,000 shares; issued and outstanding: 27,060,035 shares at March 31, 2018 and 26,898,330 shares at December 31, 2017 27 27
Additional paid-in capital 144,044 141,733
Accumulated other comprehensive loss 0 0
Accumulated deficit (73,130) (64,471)
Total stockholders’ equity 70,941 77,289
Total liabilities and stockholders’ equity $ 87,215 $ 90,391